These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 32194553)
1. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation. Barron MR; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC Front Immunol; 2020; 11():293. PubMed ID: 32194553 [TBL] [Abstract][Full Text] [Related]
2. Impaired burrowing is the most prominent behavioral deficit of aging htau mice. Geiszler PC; Barron MR; Pardon MC Neuroscience; 2016 Aug; 329():98-111. PubMed ID: 27167086 [TBL] [Abstract][Full Text] [Related]
3. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits. Koss DJ; Robinson L; Mietelska-Porowska A; Gasiorowska A; Sepčić K; Turk T; Jaspars M; Niewiadomska G; Scott RH; Platt B; Riedel G Cell Mol Life Sci; 2015 Dec; 72(23):4613-32. PubMed ID: 26070304 [TBL] [Abstract][Full Text] [Related]
4. Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model. Ferrer I; Andrés-Benito P; Ausín K; Cartas-Cejudo P; Lachén-Montes M; Del Rio JA; Fernández-Irigoyen J; Santamaría E Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742871 [TBL] [Abstract][Full Text] [Related]
5. Common and Specific Marks of Different Tau Strains Following Intra-Hippocampal Injection of AD, PiD, and GGT Inoculum in hTau Transgenic Mice. Ferrer I; Andrés-Benito P; Carmona M; Del Rio JA Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555581 [TBL] [Abstract][Full Text] [Related]
6. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology. Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048 [TBL] [Abstract][Full Text] [Related]
7. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy. Rossi F; Geiszler PC; Meng W; Barron MR; Prior M; Herd-Smith A; Loreto A; Lopez MY; Faas H; Pardon MC; Conforti L Behav Brain Res; 2018 Feb; 339():140-152. PubMed ID: 29175372 [TBL] [Abstract][Full Text] [Related]
8. Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau. de Veij Mestdagh CF; Witte ME; Scheper W; Smit AB; Henning RH; van Kesteren RE Acta Neuropathol Commun; 2024 Jun; 12(1):86. PubMed ID: 38835043 [TBL] [Abstract][Full Text] [Related]
9. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model. Helboe L; Egebjerg J; Barkholt P; Volbracht C Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086 [TBL] [Abstract][Full Text] [Related]
10. Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier. Liu Y; Zhang S; Li X; Liu E; Wang X; Zhou Q; Ye J; Wang JZ Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043530 [TBL] [Abstract][Full Text] [Related]
11. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
12. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice. Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653 [TBL] [Abstract][Full Text] [Related]
13. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. Polydoro M; Acker CM; Duff K; Castillo PE; Davies P J Neurosci; 2009 Aug; 29(34):10741-9. PubMed ID: 19710325 [TBL] [Abstract][Full Text] [Related]
14. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy. Komuro Y; Xu G; Bhaskar K; Lamb BT Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528 [TBL] [Abstract][Full Text] [Related]
15. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum. Andrés-Benito P; Carmona M; Jordán M; Fernández-Irigoyen J; Santamaría E; Del Rio JA; Ferrer I Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054902 [TBL] [Abstract][Full Text] [Related]
16. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice. Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665 [TBL] [Abstract][Full Text] [Related]